Nucala (mepolizumab) is a prescription biologic medication approved to treat several inflammatory conditions characterized by high levels of eosinophils, a type of white blood cell. It is commonly prescribed for severe eosinophilic asthma, chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis (EGPA), hypereosinophilic syndrome (HES), and eosinophilic chronic obstructive pulmonary disease (COPD).
How Nucala Works to Reduce Inflammation
Nucala works by targeting and blocking interleukin-5 (IL-5), a specific protein in the body responsible for the growth, activation, and survival of eosinophils. When eosinophil levels are too high, they can cause significant inflammation and tissue damage in the airways and other organs. By inhibiting IL-5, Nucala helps lower eosinophil counts, thereby reducing inflammation and alleviating the symptoms associated with these chronic conditions.
Dosage and Administration Methods
Nucala is administered as a subcutaneous injection under the skin of the thigh, abdomen, or upper arm. It is typically prescribed as a single injection once every four weeks. The medication comes in three distinct forms: a prefilled syringe, a prefilled auto-injector, and a lyophilized powder in a vial that must be reconstituted by a healthcare professional.
While the powder vial must always be administered in a clinical setting, some patients or caregivers may be trained by a healthcare provider to administer the prefilled syringe or auto-injector forms at home. If a dose is missed, it should be administered as soon as remembered, followed by the next scheduled dose, without doubling up to make up for the missed injection.
Common and Serious Side Effects
Like all prescription medications, Nucala can cause side effects, though not everyone experiences them. The most common mild side effects include injection site reactions (such as pain, redness, or swelling), headaches, fatigue, back pain, joint pain, and muscle spasms. Some patients may also experience mild respiratory symptoms or urinary tract infections.
Although rare, serious side effects can occur. These include severe allergic reactions (anaphylaxis) and the reactivation of the herpes zoster virus, which causes shingles. Patients should seek immediate medical attention if they experience signs of a severe allergic reaction, such as hives, swelling of the face or throat, or difficulty breathing.
Important Warnings and Drug Interactions
Before starting treatment with Nucala, patients should discuss their complete medical history with their doctor. It is crucial to note that Nucala is not a rescue medication and should not be used to treat acute asthma attacks. Patients experiencing sudden breathing difficulties must use their prescribed quick-relief rescue inhaler.
Additionally, healthcare providers should be informed if a patient has a current parasitic infection, as Nucala may weaken the body’s ability to fight off helminth infections. Patients should also discuss their vaccination status, particularly regarding the shingles vaccine, as well as pregnancy or breastfeeding plans before starting Nucala.
Leave a Reply